Improving compliance with helicobacter pylori eradication therapy: when and how?

Area of Science:

• Infectious Diseases
• Gastroenterology
• Pharmacology

Background:

• Helicobacter pylori (H. pylori) infection is a significant global health concern.
• Therapeutic compliance is the most critical determinant of successful H. pylori eradication.
• Suboptimal adherence to treatment regimens leads to significantly lower eradication rates.

Purpose of the Study:

• To identify factors influencing patient compliance with H. pylori eradication therapy.
• To explore strategies for improving adherence to H. pylori treatment.
• To emphasize the importance of patient education and physician motivation in achieving eradication.

Main Methods:

• Review of factors affecting compliance, including treatment complexity, duration, and medication characteristics.
• Discussion of the role of healthcare professionals (physicians, pharmacists, nurses) in promoting adherence.
• Exploration of pragmatic strategies like polypills, blister packs, and adjuvant therapies.

Main Results:

• Treatment complexity and duration negatively impact compliance.
• Simple, safe, tolerable, and efficacious medication regimens enhance adherence.
• Physician motivation, patient education, and a strong doctor-patient relationship are vital for compliance.

Conclusions:

• Improving compliance requires a multi-faceted approach involving patients, physicians, and healthcare systems.
• Strategies such as simplified medication delivery and structured follow-up are essential for successful H. pylori eradication.
• Engaging pharmacists and nurse specialists can further support adherence and improve patient outcomes.